EMBC · TickerCove

EMBCEmbecta Corp.Healthcare · Drug Manufacturers - Specialty & Genericas of 2026-09-16

Horizon

Issued 2026-09-16 at $5.13 · now $5.13 (2026-09-16, +0.0% since)

Based on its own history, a month from the 2026-09-16 close, EMBC has typically landed between $4.04 and $6.52 — a range of −21.2% to +27.0% from the issuance price $5.13.

Range of outcomes in historically similar periods — not a price prediction. Ranges are scored publicly on /methodology.

Actual close
Typical path (median)
Middle 50% of outcomes
90% range

1,105 overlapping 1 month windows · 2022-03-22 – 2026-08-17 · basis climatology · forecast (batch). Probability up 53.9% (90% CI 51.7–56.1%, ≈1,408 obs).

The cone is anchored at the 2026-09-16 issuance close ($5.13) — the price the forecast resolves against on 2026-10-15, not the latest close. The drawn path shape is illustrative (bands widen with √t); every labeled number is real — the anchor, the scored batch p90/IQR endpoints, and the typical move.

52-week range$5.13 · 19% of range

$2.89 low$14.72 high

Trailing 52 weeks to 2026-09-16 — factual context, not a signal.

Base rate up · monthiClimatology base rate that a US-listed stock rises over a month, with its 90% CI and ≈1,408 effective observations. Not a call on this stock — we have no evidence its odds differ.

53.9%

90% CI 51.7%–56.1%

Distribution · month iiThe price-anchored range: typical move (median), and the p90 downside/upside — 90% of similar periods stayed inside these. Ranges, not a prediction of direction.

−3.3%

typical move · IQR 19.3%

−21.2%worst (p90)+27.0%best (p90)

Insider convictioniOpen-market common-stock purchases by company insiders in the last 90 days (grants and option exercises excluded). Historical tendency, not advice — detail below.

conviction buys

0 open-market sales

Congress disclosuresiRecent disclosed congressional trades for this company. Purchase clusters (≥2 members buying within 90 days) historically preceded a modestly higher forward return (+32 bp/mo in 2022–2026, +45 bp/mo in 2015–2021) — a descriptive tendency, not a forecast input. Detail below.

0 buys · 0 sells · 0 members

cluster tilt persisted, ~halved after 2021

Where EMBC has typically landed a month from the 2026-09-16 close of $5.13 — the range is history, not a prediction.

now $5.13 (+0.0%)
typical $4.96 (-3.3%)
middle 50% $4.47–$5.46
90% range $4.04–$6.52

Actual 1-month windows behind the coneiEvery overlapping 1-month window in this security's own price history was ranked by realized return; shown are the 3 worst and 3 best of 1,105 windows spanning 2022-03-22 to 2026-09-16. Not cherry-picked — these are the extremes of the full sample. Max drop / max rise are the deepest and highest points reached within each window. See /methodology.

Start	Return	Max drop	Max rise
3 worst
2026-04-20	−69.8%	−69.8%	+0.0%
2026-04-17	−69.0%	−69.0%	+0.0%
2026-04-15	−67.3%	−67.5%	+1.8%
3 best
2026-07-22	+68.3%	+0.0%	+68.3%
2026-08-06	+65.7%	+0.0%	+65.7%
2026-07-23	+60.9%	+0.0%	+68.3%

1,105 overlapping windows · 2022-03-22 – 2026-09-16 · not cherry-picked

Seasonality · by month i

iFor each calendar month, the share of years this security closed higher than the month before, and the average month-over-month return, over ~5 years of its own price history. Cells are shaded by average return. This is historical frequency, not a prediction — no month is a signal.

Jan

25%

−7.2%

n=4

Feb

25%

−5.0%

n=4

Mar

−9.6%

n=4

Apr

20%

−6.9%

n=5

May

40%

−14.1%

n=5

Jun

40%

−6.0%

n=5

Jul

80%

+11.4%

n=5

Aug

80%

+17.3%

n=5

Sep

−8.8%

n=5

Oct

50%

+0.6%

n=4

Nov

75%

+17.8%

n=4

Dec

25%

−6.1%

n=4

Up-frequency and average month-over-month return · historical frequency, not a prediction

Reported insider & political trades

Every Form 4 the people closest to this company have filed with the SEC — plotted against the share price, aggregated by month, and shown with the gap between when each trade happened and when it was disclosed. A public record, not advice.

Date	Person	Role	Action	Shares @ price	Value	Ownership Δ	vs S&P 1m	vs S&P 6m	Owned after	Filing
2026-09-04	Morris Milton Mayo	director	Sale	6,293 @ $5.88	$37K	−10.5% of holding	not yet — horizon still open	not yet — horizon still open	53,828	Form 4 · filed 4 days after the trade
2026-08-12	HOMBACH ROBERT J.	director	Purchase	45,000 @ $4.97	$224K	+69.7% of holding	+5.1%	not yet — horizon still open	109,587	Form 4 · filed 1 day after the trade
2026-08-12	Kurdikar Devdatt	director	Purchase	30,000 @ $4.70	$141K	+3.9% of holding	+5.1%	not yet — horizon still open	804,919	Form 4 · filed 1 day after the trade
2026-08-12	Mann Jeffrey Z	officer	Purchase	20,000 @ $4.99	$100K	+8.2% of holding	+5.1%	not yet — horizon still open	262,915	Form 4 · filed 1 day after the trade
2026-08-12	Elguicze Jacob	officer	Purchase	20,000 @ $4.67	$93K	+6.9% of holding	+5.1%	not yet — horizon still open	309,139	Form 4 · filed 1 day after the trade
2025-05-23	Melcher David F	director	Purchase	10,000 @ $10.60	$106K	+13.0% of holding	−11.3%	+24.6%	86,681	Form 4 · filed same day
2025-02-25	Melcher David F	director	Purchase	13,000 @ $13.67	$178K	+20.4% of holding	−1.0%	−0.0%	76,681	Form 4 · filed same day
2025-02-13	Morris Milton Mayo	director	Sale	3,100 @ $16.38	$51K	−7.9% of holding	−7.7%	−19.4%	36,133	Form 4 · filed 1 day after the trade

The vs-S&P columns are a labeled look-back on what the stock did after each filing, measured against the index over the same window. Descriptive history, not a claim about the person or a reason to trade.

37 award / exercise / gift records — not counted as purchases

Awards, option exercises, gifts and tax-withholding disposals are shown separately and never counted as open-market purchases or sales — they carry no conviction information.

Date	Person	Role	Action	Shares	Owned after	Filing
2026-08-09	Casner Jean	officer	Withheld for tax	1,480	85,915	Form 4
2026-06-01	Roth Anthony M.	officer	Award / grant	30,000	78,833	Form 4
2026-02-11	Prange Karen	director	Award / grant	22,841	64,581	Form 4
2026-02-11	Morris Milton Mayo	director	Award / grant	22,841	60,121	Form 4
2026-02-11	HOMBACH ROBERT J.	director	Award / grant	22,841	64,587	Form 4
2026-02-11	Reidy Christopher R	director	Award / grant	22,841	70,122	Form 4
2026-02-11	Pomeroy Claire	director	Award / grant	22,841	66,127	Form 4
2026-02-11	Anderson Carrie L	director	Award / grant	22,841	64,581	Form 4
2025-11-26	Kurdikar Devdatt	director	Withheld for tax	128,630	774,919	Form 4
2025-11-26	Elguicze Jacob	officer	Withheld for tax	24,782	273,228	Form 4
2025-11-26	Mann Jeffrey Z	officer	Withheld for tax	19,605	227,004	Form 4
2025-11-26	Curtis Shaun	officer	Withheld for tax	15,380	95,324	Form 4
2025-11-26	Casner Jean	officer	Withheld for tax	3,325	84,705	Form 4
2025-11-26	Roth Anthony M.	officer	Withheld for tax	1,881	47,415	Form 4
2025-11-26	Elguicze Jacob	officer	Award / grant	30,147	298,010	Form 4
2025-11-26	Kurdikar Devdatt	director	Award / grant	288,386	799,923	Form 4
2025-11-26	Kurdikar Devdatt	director	Award / grant	103,626	903,549	Form 4
2025-11-26	Elguicze Jacob	officer	Award / grant	95,466	267,863	Form 4
2025-11-26	Mann Jeffrey Z	officer	Award / grant	79,555	222,114	Form 4
2025-11-26	Mann Jeffrey Z	officer	Award / grant	24,495	246,609	Form 4
2025-11-26	Curtis Shaun	officer	Award / grant	11,305	110,704	Form 4
2025-11-26	Roth Anthony M.	officer	Award / grant	32,817	49,296	Form 4
2025-11-26	Curtis Shaun	officer	Award / grant	37,789	99,399	Form 4
2025-11-26	Casner Jean	officer	Award / grant	38,783	88,030	Form 4
2025-08-09	Casner Jean	officer	Withheld for tax	916	48,799	Form 4
2025-04-04	Kurdikar Devdatt	director	Withheld for tax	39,592	499,582	Form 4
2025-04-04	Mann Jeffrey Z	officer	Withheld for tax	5,285	139,439	Form 4
2025-04-04	Elguicze Jacob	officer	Withheld for tax	4,948	168,599	Form 4
2025-04-04	Curtis Shaun	officer	Withheld for tax	3,249	59,061	Form 4
2025-02-12	HOMBACH ROBERT J.	director	Award / grant	13,839	39,749	Form 4
2025-02-12	Pomeroy Claire	director	Award / grant	13,839	41,289	Form 4
2025-02-12	Reidy Christopher R	director	Award / grant	13,839	45,284	Form 4
2025-02-12	Prange Karen	director	Award / grant	13,839	39,743	Form 4
2025-02-12	Anderson Carrie L	director	Award / grant	13,839	39,743	Form 4
2025-02-12	Albritton David	director	Award / grant	13,839	39,743	Form 4
2025-02-12	Morris Milton Mayo	director	Award / grant	13,839	39,233	Form 4
2025-02-12	Melcher David F	director	Award / grant	17,450	63,681	Form 4

Source: SEC Form 4 filings. Each row links to its original filing.

Across 2012–2021, stocks where a CEO, C-suite officer, or director had recently made an open-market common-stock purchase ran about +28 bp per month above the universe average (n=34,268 stock-weeks). A historical tendency, not a prediction.

Congressional disclosures

No congressional trades disclosed for this company.

Resolves in i

28d remaining

2026-09-173% elapsed2026-10-15

Logged immutably 2026-09-17; scored automatically on 2026-10-15 — no edits, ever.

Earnings & context analysis

These panels are being prepared. They are generated by multiple language models, checked, and stored before display — never written live for a page view. Until a model panel has been generated and reviewed for a company, nothing is shown here, honestly, rather than a placeholder.

Calibration i

Every forecast is logged when made and scored when the month is up. The record is shown from the day it starts — young and honest.

How scoring works →

Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.

Seasonality · by month iHow this security has tended to do in each calendar month historically — a frequency, never a prediction.

Reported insider & political trades

Congressional disclosures

Seasonality · by month i